n-Lorem received a $3 million donation to support its efforts in ASO research and discovery
Parexel to provide clinical operations, real-world data solutions and expertise including medical and regulatory alongside innovative clinical research tools that will significantly enhance and streamline n-Lorem’s therapeutic development efforts
World’s largest oligonucleotide manufacturer provides drug ingredients and financial donation to support development of experimental antisense medicines, helping n-Lorem reach more patients
n-Lorem’s third partnership in the last quarter boosts resources to assist patients with ultra-rare mutations